vs
Side-by-side financial comparison of DONEGAL GROUP INC (DGICA) and iRhythm Holdings, Inc. (IRTC). Click either name above to swap in a different company.
DONEGAL GROUP INC is the larger business by last-quarter revenue ($236.0M vs $208.9M, roughly 1.1× iRhythm Holdings, Inc.). DONEGAL GROUP INC runs the higher net margin — 4.9% vs 2.7%, a 2.2% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs -3.7%). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs -2.2%).
Donegal Group Inc. is a regional US insurance holding company offering personal and commercial property and casualty insurance products. It serves Mid-Atlantic, Midwest, and Southern US customers, delivering tailored coverage for individuals, families, and small to medium businesses.
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
DGICA vs IRTC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $236.0M | $208.9M |
| Net Profit | $11.5M | $5.6M |
| Gross Margin | — | 70.9% |
| Operating Margin | — | 1.1% |
| Net Margin | 4.9% | 2.7% |
| Revenue YoY | -3.7% | 27.1% |
| Net Profit YoY | -54.3% | 518.5% |
| EPS (diluted) | — | $0.18 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $236.0M | — | ||
| Q4 25 | $239.8M | $208.9M | ||
| Q3 25 | $245.9M | $192.9M | ||
| Q2 25 | $247.1M | $186.7M | ||
| Q1 25 | $245.2M | $158.7M | ||
| Q4 24 | $250.0M | $164.3M | ||
| Q3 24 | $251.7M | $147.5M | ||
| Q2 24 | $246.8M | $148.0M |
| Q1 26 | $11.5M | — | ||
| Q4 25 | $17.2M | $5.6M | ||
| Q3 25 | $20.1M | $-5.2M | ||
| Q2 25 | $16.9M | $-14.2M | ||
| Q1 25 | $25.2M | $-30.7M | ||
| Q4 24 | $24.0M | $-1.3M | ||
| Q3 24 | $16.8M | $-46.2M | ||
| Q2 24 | $4.2M | $-20.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | 70.9% | ||
| Q3 25 | — | 71.1% | ||
| Q2 25 | — | 71.2% | ||
| Q1 25 | — | 68.8% | ||
| Q4 24 | — | 70.0% | ||
| Q3 24 | — | 68.8% | ||
| Q2 24 | — | 69.9% |
| Q1 26 | — | — | ||
| Q4 25 | 8.7% | 1.1% | ||
| Q3 25 | 10.2% | -4.4% | ||
| Q2 25 | 8.3% | -10.0% | ||
| Q1 25 | 12.7% | -20.5% | ||
| Q4 24 | 11.9% | -2.5% | ||
| Q3 24 | 8.1% | -34.1% | ||
| Q2 24 | 2.0% | -15.5% |
| Q1 26 | 4.9% | — | ||
| Q4 25 | 7.2% | 2.7% | ||
| Q3 25 | 8.2% | -2.7% | ||
| Q2 25 | 6.8% | -7.6% | ||
| Q1 25 | 10.3% | -19.3% | ||
| Q4 24 | 9.6% | -0.8% | ||
| Q3 24 | 6.7% | -31.3% | ||
| Q2 24 | 1.7% | -13.6% |
| Q1 26 | — | — | ||
| Q4 25 | — | $0.18 | ||
| Q3 25 | — | $-0.16 | ||
| Q2 25 | — | $-0.44 | ||
| Q1 25 | — | $-0.97 | ||
| Q4 24 | — | $-0.03 | ||
| Q3 24 | — | $-1.48 | ||
| Q2 24 | — | $-0.65 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $583.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $649.1M | $152.7M |
| Total Assets | $2.4B | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $583.8M | ||
| Q3 25 | — | $565.2M | ||
| Q2 25 | — | $545.5M | ||
| Q1 25 | — | $520.6M | ||
| Q4 24 | — | $535.6M | ||
| Q3 24 | — | $522.0M | ||
| Q2 24 | — | $561.5M |
| Q1 26 | $649.1M | — | ||
| Q4 25 | $640.4M | $152.7M | ||
| Q3 25 | $627.4M | $121.9M | ||
| Q2 25 | $605.7M | $103.7M | ||
| Q1 25 | $584.7M | $86.7M | ||
| Q4 24 | $545.8M | $90.9M | ||
| Q3 24 | $513.4M | $71.8M | ||
| Q2 24 | $484.1M | $99.2M |
| Q1 26 | $2.4B | — | ||
| Q4 25 | $2.4B | $1.0B | ||
| Q3 25 | $2.4B | $995.2M | ||
| Q2 25 | $2.4B | $964.0M | ||
| Q1 25 | $2.4B | $926.1M | ||
| Q4 24 | $2.3B | $931.4M | ||
| Q3 24 | $2.3B | $909.7M | ||
| Q2 24 | $2.3B | $919.2M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $26.2M |
| Free Cash FlowOCF − Capex | — | $14.5M |
| FCF MarginFCF / Revenue | — | 6.9% |
| Capex IntensityCapex / Revenue | — | 5.6% |
| Cash ConversionOCF / Net Profit | — | 4.70× |
| TTM Free Cash FlowTrailing 4 quarters | — | $34.5M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $70.2M | $26.2M | ||
| Q3 25 | $22.4M | $34.9M | ||
| Q2 25 | $12.1M | $27.7M | ||
| Q1 25 | $25.7M | $-7.9M | ||
| Q4 24 | $67.4M | $19.2M | ||
| Q3 24 | $12.7M | $24.3M | ||
| Q2 24 | $21.7M | $11.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $14.5M | ||
| Q3 25 | — | $20.1M | ||
| Q2 25 | — | $17.3M | ||
| Q1 25 | — | $-17.3M | ||
| Q4 24 | — | $12.4M | ||
| Q3 24 | — | $15.5M | ||
| Q2 24 | — | $3.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 6.9% | ||
| Q3 25 | — | 10.4% | ||
| Q2 25 | — | 9.3% | ||
| Q1 25 | — | -10.9% | ||
| Q4 24 | — | 7.5% | ||
| Q3 24 | — | 10.5% | ||
| Q2 24 | — | 2.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.6% | ||
| Q3 25 | — | 7.7% | ||
| Q2 25 | — | 5.6% | ||
| Q1 25 | — | 5.9% | ||
| Q4 24 | — | 4.2% | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.7% |
| Q1 26 | — | — | ||
| Q4 25 | 4.08× | 4.70× | ||
| Q3 25 | 1.11× | — | ||
| Q2 25 | 0.72× | — | ||
| Q1 25 | 1.02× | — | ||
| Q4 24 | 2.81× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | 5.22× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DGICA
Segment breakdown not available.
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
